This new issue contains the following articles: Review Articles Pediatric asthma exacerbation and COVID-19 pandemic: Impacts, challenges, and future considerations Soroush Khojasteh-Kaffash, Peyvand Parhizkar Roudsari, Amir Ghaffari Jolfayi, MD-MPH, MME, Noosha Samieefar, MD, MPH & Nima Rezaei, MD, PhD Pages: 81-91 | DOI: 10.1080/02770903.2023.2251062 Telemonitoring in patients with asthma: a systematic review Lida Fadaizadeh, MD, Farnia Velayati, PhD & Mohammad Sanaat, MSc Pages: 92-104 | DOI: 10.1080/02770903.2023.2255267 Research Articles Correlation of vitamin D receptor genotypes, specific IgE levels and other variables with asthma control in children Walid Al-Qerem, PhD, Anan Jarab, PhD, Yazun Jarrar, PhD, Enas Al-Zayadneh, MD, Montaha Al-Iede, MD, Jonathan Ling, PhD, Khawla Abu Hammour, PhD, Sally S. Alabdullah, BSc, MD, Asal Saad Alabdullah, BSc, Yamam Al Refaie, BSc, Dina Lubbad, BSc, Ameen Alassi, MSc, Sarah Ibrahim, MSc, Mahmood Al-Ibadah, MSc & Abdel Qader Al Bawab, PhD Pages: 105-118 | DOI: 10.1080/02770903.2023.2244580 Genetic relationships between high blood eosinophil count, asthma susceptibility, and asthma severity Huashi Li, MS & Xingnan Li, PhD Pages: 119-131 | DOI: 10.1080/02770903.2023.2247490 In symptomatic patients on as-needed inhaled corticosteroids-formoterol, VAS asthma is associated with small airways resistance Ilgim Vardaloglu, MD, Bernardo Sousa-Pinto, MD, PhD, Jean Bousquet, MD, PhD, Peter Dodek, MD, M.HSC, Anna Bedbrook, BSc, Mert Karatas, MD & Bilun Gemicioglu, MD, PhD Pages: 132-139 | DOI: 10.1080/02770903.2023.2248485 Feasibility of text message follow-up for pediatric asthma care after an emergency department visit Kaitlin Hall, MD, MPH, MS, Frances Barry, MA, Lindsey R. Thompson, MS, MPH, Bahareh Ravandi, MD, Jeanine E. Hall, MD, Todd P. Chang, MD, MAcM, Jill S. Halterman, MD, MPH, Peter G. Szilagyi, MD, MPH & Sande O. Okelo, MD, PhD Pages: 140-147 | DOI: 10.1080/02770903.2023.2248507 Health-related quality of life, anxiety, depression, beliefs of medication, and self-efficacy in individuals with severe asthma – a population-based study | L. Rönnebjerg, MSc(Nurs.), M. Axelsson, PhD, H. Kankaanranta, MD, PhD & L. Ekerljung, MD, PhD Pages: 148-159 | DOI: 10.1080/02770903.2023.2248512 Possible role of HE4 level elevation in the pathogenesis of TH2-high asthma Kan Zhang, PhD, Yu Cao, MB, Hexuan Tang, PhD & Dang Lin, MB Pages: 160-172 | DOI: 10.1080/02770903.2023.2251056 Case Report Efficacy of mepolizumab and omalizumab combination therapy in uncontrolled asthma Mehmet Emin Sezgin, MD, Mustafa Çolak, MD, Özge Çağlayan, MD, Merve Yumrukuz Şenel, MD, Esma Nur Aktepe Sezgin, MD, Hikmet Çoban, MD, Nurhan Sarıoğlu, MD, Bilun Gemicioğlu, MD & Fuat Erel, MD Pages: 173-175 | DOI: 10.1080/02770903.2023.2244590 |
Recent Posts
- Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment
- Breakingthrough for treating asthma attacks | New asthma treatment
- Biologics and airway remodeling in asthma: early, late, and potential preventive effects
- Triple inhaled therapy in asthma: beliefs, behaviours and doubts
- Comparison of impulse oscillometry measurements according to body mass index in patients with asthma